Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.55 +0.03 (5.77%)
Previous Close $0.52    52 Week High
Open $0.56    52 Week Low
Day High $0.56    P/E N/A 
Day Low $0.53    EPS
Volume 26,933